lactoferrin and Laryngeal-Neoplasms

lactoferrin has been researched along with Laryngeal-Neoplasms* in 2 studies

Other Studies

2 other study(ies) available for lactoferrin and Laryngeal-Neoplasms

Article	Year
Lactoferrin-tethered betulinic acid nanoparticles promote rapid delivery and cell death in triple negative breast and laryngeal cancer cells. Artificial cells, nanomedicine, and biotechnology, 2020, Nov-17, Volume: 48, Issue:1 Topics: Antineoplastic Agents; Apoptosis; Betulinic Acid; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Carriers; Humans; Lactoferrin; Laryngeal Neoplasms; Nanoparticles; Particle Size; Pentacyclic Triterpenes; Triple Negative Breast Neoplasms	2020
[Content of protein lactoferrin in precancer laryngeal disease]. Vestnik otorinolaringologii, 2003, Issue:5 Lactoferrin was studied in 50 patients with laryngeal precancer: chronic hyperplastic laryngitis (n=28), leukoplakia (n=22). Lactoferrin was measured before the treatment, 10-12 days and 12 months after the treatment. Blood serum concentration of lactoferrin was significantly increased before the treatment. By the authors, it was due to inflammation in laryngeal tissues. Conservative treatment of patients with chronic hyperplastic laryngitis resulted in a considerable reduction in this protein concentration. Surgical removal of leukoplakias stimulated laryngeal inflammation and raised lactoferrin concentration in blood serum. One year after the examination, those patients who had neither exacerbation of chronic hyperplastic laryngitis no recurrent leukoplakia exhibited serum lactoferrin in concentrations close to the baseline but still higher than in healthy individuals. This is explained by chronicity of inflammation in laryngeal tissues. These findings can be used in diagnosis and prognosis of the disease course in patients with laryngeal precancer. Topics: Adult; Humans; Lactoferrin; Laryngeal Neoplasms; Leukoplakia, Oral; Male; Precancerous Conditions	2003

Article

Year

Lactoferrin-tethered betulinic acid nanoparticles promote rapid delivery and cell death in triple negative breast and laryngeal cancer cells.

Artificial cells, nanomedicine, and biotechnology, 2020, Nov-17, Volume: 48, Issue:1

Topics: Antineoplastic Agents; Apoptosis; Betulinic Acid; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Carriers; Humans; Lactoferrin; Laryngeal Neoplasms; Nanoparticles; Particle Size; Pentacyclic Triterpenes; Triple Negative Breast Neoplasms

2020

[Content of protein lactoferrin in precancer laryngeal disease].

Vestnik otorinolaringologii, 2003, Issue:5

Lactoferrin was studied in 50 patients with laryngeal precancer: chronic hyperplastic laryngitis (n=28), leukoplakia (n=22). Lactoferrin was measured before the treatment, 10-12 days and 12 months after the treatment. Blood serum concentration of lactoferrin was significantly increased before the treatment. By the authors, it was due to inflammation in laryngeal tissues. Conservative treatment of patients with chronic hyperplastic laryngitis resulted in a considerable reduction in this protein concentration. Surgical removal of leukoplakias stimulated laryngeal inflammation and raised lactoferrin concentration in blood serum. One year after the examination, those patients who had neither exacerbation of chronic hyperplastic laryngitis no recurrent leukoplakia exhibited serum lactoferrin in concentrations close to the baseline but still higher than in healthy individuals. This is explained by chronicity of inflammation in laryngeal tissues. These findings can be used in diagnosis and prognosis of the disease course in patients with laryngeal precancer.

Topics: Adult; Humans; Lactoferrin; Laryngeal Neoplasms; Leukoplakia, Oral; Male; Precancerous Conditions

2003